2025 Speakers 2025 Expert Speaker Faculty Take a look at the esteemed speaker faculty for the 9th MASH Drug Development Summit. Belle Van Rosmalen Director, Medical Development Eli Lilly Caleb Roberts Vice President, Business Development Antaros Medical Cynthia Arbeeny CSO Mitotherapeutix Cynthia Lebeaupin Senior Scientist, Inflammation & Immunology R&D Pfizer Erik Tillman Director, Translational Biology and Pharmacology Akero Therapeutics Hank Mansbach Chief Medical Officer 89 Bio Jen-Chieh Chuang Director, Translational Biomarker Lead, Liver Diseases Takeda Pharmaceuticals Kavita Juneja VP Clin Dev Corcept Therapeutics Kevin Hart Associate Director - Scientific Research Fellow Pfizer Marie O’Farrell Senior Vice President - Research & Development Sagimet Biosciences Oliver Yoa-Pu Hu Scientific Board Member Sinew Pharma PATRICE MIMCHE Associate Professor Indiana University Rebecca Taub Founder & Director Madrigal Remi Laberge CTO Arda Therapeutics Saheli Chowdhury Postdoctoral Research Scientist Columbia University Sharon Jaycox Director Global Liver Institute Stan Watowich Founder & Chief Executive Officer Ridgeline Therapeutics Wen-Wei Tsai Senior Director Sagimet Biosciences Winston Dunn Professor University of Kansas Medical Center Zoltan Derdak Director - Medical Takeda Pharmaceuticals 2025 Event Guide Register Interest Partner